-
Adoptive T-cell therapies to overcome T cell-dependent immune dysregulations in COVID-19
SEVGİ KALKANLI TAŞ, MERVE SAİDE UZUNOĞLU, AYLİN SEHER UZUNOĞLU, DUYGU KIRKIK, DERYA ALTUNKANAT, NEVİN KALKANLI
Turk J Biol, 46, (2022), 105-117
-
The comparison of differentially expressed microRNAs in Bag-1 deficient and wild type MCF-7 breast cancer cells by small RNA sequencing
PELİN ÖZFİLİZ KILBAŞ, GİZEM ALKURT, PINAR OBAKAN YERLİKAYA, AJDA ÇOKER GÜRKAN, GİZEM DİNLER DOĞANAY, ELİF DAMLA ARISAN
Turk J Biol, 46, (2022), 118-136
-
Doxorubicin-induced transcriptome meets interactome: identification of new drug targets
HİLAL TAYMAZ-NİKEREL
Turk J Biol, 46, (2022), 137-144
-
Developing a label propagation approach for cancer subtype identification problem
PINAR GÜNER, BURCU GÜNGÖR, MUSTAFA COŞKUN
Turk J Biol, 46, (2022), 145-161
-
Melatonin ameliorates cisplatin-induced neurodegeneration in medulla oblongata through the expressions of Aqp-1,-4, inflammation and apoptosis pathway genes
RAHİME ÖZLEM ÖZTOPUZ
Turk J Biol, 46, (2022), 162-172
-
Bone marrow mesenchymal stem cells attenuate LPS-induced acute lung injury in mice by promoting RvE1/ProD1 and modulating Treg/Th17 balance
HE-BU QIAN, GUIJUAN ZOU, CHAO LI, QIFANG HE, JUN LIU
Turk J Biol, 46, (2022), 173-185
-
Regulatory roles of an atypical ubiquitin ligase UBE2O in orphans of multi-protein complexes for degradation
YI LV, FEIYUE XING
Turk J Biol, 46, (2022), 186-194